These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 32013182)

  • 1. Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of
    Atzori A; Malloci G; Cardamone F; Bosin A; Vargiu AV; Ruggerone P
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of carbapenem binding sites within the RND-transporter AcrB.
    Atzori A; Malviya VN; Malloci G; Dreier J; Pos KM; Vargiu AV; Ruggerone P
    Biochim Biophys Acta Biomembr; 2019 Jan; 1861(1):62-74. PubMed ID: 30416087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
    Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
    mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
    Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Interactions of Cephalosporins with the Deep Binding Pocket of the RND Transporter AcrB.
    Atzori A; Malloci G; Prajapati JD; Basciu A; Bosin A; Kleinekathöfer U; Dreier J; Vargiu AV; Ruggerone P
    J Phys Chem B; 2019 Jun; 123(22):4625-4635. PubMed ID: 31070373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer simulations suggest direct and stable tip to tip interaction between the outer membrane channel TolC and the isolated docking domain of the multidrug RND efflux transporter AcrB.
    Schmidt TH; Raunest M; Fischer N; Reith D; Kandt C
    Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1419-26. PubMed ID: 27045078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
    Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate-dependent transport mechanism in AcrB of multidrug resistant bacteria.
    Jewel Y; Van Dinh Q; Liu J; Dutta P
    Proteins; 2020 Jul; 88(7):853-864. PubMed ID: 31998988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis for the different interactions of congeneric substrates with the polyspecific transporter AcrB.
    Malvacio I; Buonfiglio R; D'Atanasio N; Serra G; Bosin A; Di Giorgio FP; Ruggerone P; Ombrato R; Vargiu AV
    Biochim Biophys Acta Biomembr; 2019 Jul; 1861(7):1397-1408. PubMed ID: 31075229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug binding properties of the AcrB efflux pump characterized by molecular dynamics simulations.
    Vargiu AV; Nikaido H
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20637-42. PubMed ID: 23175790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perturbed structural dynamics underlie inhibition and altered efflux of the multidrug resistance pump AcrB.
    Reading E; Ahdash Z; Fais C; Ricci V; Wang-Kan X; Grimsey E; Stone J; Malloci G; Lau AM; Findlay H; Konijnenberg A; Booth PJ; Ruggerone P; Vargiu AV; Piddock LJV; Politis A
    Nat Commun; 2020 Nov; 11(1):5565. PubMed ID: 33149158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli resistance mechanism AcrAB-TolC efflux pump interactions with commonly used antibiotics: a molecular dynamics study.
    Smith BL; Fernando S; King MD
    Sci Rep; 2024 Feb; 14(1):2742. PubMed ID: 38302495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Water-mediated interactions enable smooth substrate transport in a bacterial efflux pump.
    Vargiu AV; Ramaswamy VK; Malvacio I; Malloci G; Kleinekathöfer U; Ruggerone P
    Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):836-845. PubMed ID: 29339082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.
    Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R
    J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AcrB-AcrA Fusion Proteins That Act as Multidrug Efflux Transporters.
    Hayashi K; Nakashima R; Sakurai K; Kitagawa K; Yamasaki S; Nishino K; Yamaguchi A
    J Bacteriol; 2016 Jan; 198(2):332-42. PubMed ID: 26527645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RND efflux pumps: structural information translated into function and inhibition mechanisms.
    Ruggerone P; Murakami S; Pos KM; Vargiu AV
    Curr Top Med Chem; 2013; 13(24):3079-100. PubMed ID: 24200360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional analysis of the promiscuous AcrB and AdeB efflux pumps suggests different drug binding mechanisms.
    Ornik-Cha A; Wilhelm J; Kobylka J; Sjuts H; Vargiu AV; Malloci G; Reitz J; Seybert A; Frangakis AS; Pos KM
    Nat Commun; 2021 Nov; 12(1):6919. PubMed ID: 34824229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AcrB: a mean, keen, drug efflux machine.
    Kobylka J; Kuth MS; Müller RT; Geertsma ER; Pos KM
    Ann N Y Acad Sci; 2020 Jan; 1459(1):38-68. PubMed ID: 31588569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the inhibition of the drug efflux protein AcrB using surface plasmon resonance.
    Mowla R; Wang Y; Ma S; Venter H
    Biochim Biophys Acta Biomembr; 2018 Apr; 1860(4):878-886. PubMed ID: 28890187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
    Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.